Petefészekrák: vizsgálatok itt: Ausztria
13 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Where
- Graz, Innsbruck, Vienna
- Életkor
- 18 év and over
- People
- 1630 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07213804 · EU 2025-522255-25-00 - 3. fázisTaking peopleStudy of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Where
- Innsbruck, Vienna
- Életkor
- 18 év and over
- People
- 582 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06819007 · EU 2024-516982-35-00 - No phaseTaking peopleReal-World Study of Mirvetuximab Soravtansine in Adult Participants With Platinum-Resistant FRα-Positive Ovarian, Fallopian Tube, and Peritoneal Cancer
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 500
- Run by
- AbbVie
See details and how to joinNCT07896421 - 2. fázisTaking peopleA Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy
- Where
- Innsbruck
- Életkor
- 18 év and over
- People
- 640 worldwide
- Run by
- North Eastern German Society of Gynaecological Oncology
See details and how to joinNCT05460000 · EU 2022-502559-69-01 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- Where
- Graz, Innsbruck, Linz, Vienna
- Életkor
- 18 év and over
- People
- 770 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06824467 · EU 2023-508015-23-00 - 3. fázisTaking peopleA Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
- Where
- Innsbruck, Linz, Vienna
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07318558 · EU 2023-508047-40-00 - 3. fázisTaking peopleStudy to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
- Where
- Feldkirch Vorarlberg, Graz, Innsbruck, Vienna
- Életkor
- 18 év and over
- People
- 544 worldwide
- Run by
- Genmab
See details and how to joinNCT07225270 · EU 2025-522167-15-00 - 2. fázisTaking peopleA Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
- Where
- Graz, Vienna
- Életkor
- 18 év and over
- People
- 37 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT04641247 · EU 2023-506618-29-00 - No phaseTaking peopleTUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
- Where
- Graz
- Életkor
- 25 év to 50 év
- People
- 3000 worldwide
- Run by
- University Medical Center Nijmegen
See details and how to joinNCT04294927 - 2. fázisTaking peopleCATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- Where
- Graz, Innsbruck, Linz, Vienna
- Életkor
- 18 év and over
- People
- 230 worldwide
- Run by
- TORL Biotherapeutics, LLC
See details and how to joinNCT06690775 · EU 2024-517190-24-00 - 3. fázisTaking peopleMAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
- Where
- Graz, Innsbruck, Leoben, Linz, Salzburg, Vienna
- Életkor
- 18 év and over
- People
- 540 worldwide
- Run by
- Swiss GO Trial Group
See details and how to joinNCT04111978 · EU 2024-511219-78-00 - No phaseTaking peopleEstablishment of a Tumor Bank for Blood Samples
- Where
- Innsbruck
- Életkor
- 18 év and over
- People
- 10 000 worldwide
- Run by
- Medical University of Vienna
See details and how to joinNCT01763125 - No phaseTaking peopleEstablishment of a Tumor Bank for Tissue Samples
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 10 000 worldwide
- Run by
- Medical University of Vienna
See details and how to joinNCT01789229